Selective serotonin reuptake inhibitor
Selective serotonin reuptake inhibitor is a pharmaceutical drug with 7 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 7 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
3
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
7 of 7 finished
0.0%
0 ended early
0
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
An Adaptive Algorithm-Based Approach to Treatment for Adolescent Depression
Sequenced Treatment Effectiveness for Posttraumatic Stress
Hyaluronic Acid Injection in the Glans Penis Versus Selective Serotonin Reuptake Inhibitors for Lifelong Premature
Predicting Treatment Response in Patients With OCD
The ISLAND Study: InSuLa Assessed Needs for Depression
Clinical Trials (7)
An Adaptive Algorithm-Based Approach to Treatment for Adolescent Depression
Sequenced Treatment Effectiveness for Posttraumatic Stress
Hyaluronic Acid Injection in the Glans Penis Versus Selective Serotonin Reuptake Inhibitors for Lifelong Premature
Predicting Treatment Response in Patients With OCD
The ISLAND Study: InSuLa Assessed Needs for Depression
Success of Inferior Alveolar Nerve Block in Women Taking Selective Serotonin Reuptake Inhibitors
Music Therapy in Obsessive Compulsive Disorder
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7